BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30942648)

  • 1. Limited stage grade 3 follicular lymphoma patients can experience favorable outcomes with combined modality therapy.
    Ayoub Z; Andraos T; Milgrom SA; Pinnix CC; Dabaja BS; Ng SP; Gunther JR; Khoury JD; Fowler NH; Neelapu SS; Samaniego F; Fayad LE; Nastoupil LJ
    Leuk Lymphoma; 2019 Oct; 60(10):2432-2440. PubMed ID: 30942648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline-Based Therapy.
    Yuan J; Greiner TC; Fu K; Smith LM; Aoun P; Chan WC; Bierman PJ; Bociek RG; Vose JM; Armitage JO; Weisenburger DD
    Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):488-497.e2. PubMed ID: 28842137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Stage Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes.
    Andraos T; Ayoub Z; Nastoupil L; Pinnix C; Milgrom S; Gunther J; Ng SP; Fowler N; Neelapu S; Samaniego F; Dabaja B
    Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):381-389. PubMed ID: 30935940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional therapy improves outcomes in completely resected, limited-stage follicular lymphoma.
    Andraos TY; Ayoub Z; Nastoupil LJ; Milgrom SA; Pinnix CC; Ng SP; Gunther JR; Fowler NH; Neelapu SS; Samaniego F; Fayad LE; Dabaja BS
    Leuk Lymphoma; 2019 Dec; 60(13):3258-3265. PubMed ID: 31234671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long term follow-up of early stage follicular lymphoma treated with radiotherapy, chemotherapy or combined modality treatment.
    Sancho JM; García O; Mercadal S; Pomares H; Fernández-Alvarez R; González-Barca E; Tapia G; González-García E; Moreno M; Domingo-Domènech E; Sorigué M; Navarro JT; Motlló C; Fernández-de-Sevilla A; Feliu E; Ribera JM
    Leuk Res; 2015 Aug; 39(8):853-8. PubMed ID: 26122511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early stage W.H.O. grade I and II follicular lymphoma treated with radiation therapy alone.
    Ahmed N; Owen TE; Rubinger M; Williams G; Nugent Z; Ahmed S; Cooke A
    PLoS One; 2013; 8(6):e65156. PubMed ID: 23762303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome and mortality trends in early-stage, Grade 1-2 follicular lymphoma treated with radiation therapy.
    Guadagnolo BA; Li S; Neuberg D; Ng A; Hua L; Silver B; Stevenson MA; Mauch P
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):928-34. PubMed ID: 16243446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grade 3 Follicular Lymphoma: Outcomes in the Rituximab Era.
    Mustafa Ali M; Rybicki L; Nomani L; Rouphail B; Dean RM; Hill BT; Jagadeesh D; Pohlman B; Hsi ED; Smith MR
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):797-803. PubMed ID: 28789937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study.
    Ruella M; Filippi AR; Bruna R; Di Russo A; Magni M; Caracciolo D; Passera R; Matteucci P; Di Nicola M; Corradini P; Parvis G; Gini G; Olivieri A; Ladetto M; Ricardi U; Tarella C; Devizzi L
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):783-91. PubMed ID: 26972651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
    Sureda A; Zhang MJ; Dreger P; Carreras J; Fenske T; Finel H; Schouten H; Montoto S; Robinson S; Smith SM; Boumedil A; Hamadani M; Pasquini MC
    Cancer; 2018 Apr; 124(8):1733-1742. PubMed ID: 29424927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of histologic grade and Ki-67 proliferation index in follicular lymphoma.
    Xue T; Yu BH; Yan WH; Jiang XN; Tian T; Zhou XY; Li XQ
    Hematol Oncol; 2020 Dec; 38(5):665-672. PubMed ID: 32627854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience.
    Ganti AK; Weisenburger DD; Smith LM; Hans CP; Bociek RG; Bierman PJ; Vose JM; Armitage JO
    Ann Oncol; 2006 Jun; 17(6):920-7. PubMed ID: 16524969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups.
    Batlevi CL; Sha F; Alperovich A; Ni A; Smith K; Ying Z; Soumerai JD; Caron PC; Falchi L; Hamilton A; Hamlin PA; Horwitz SM; Joffe E; Kumar A; Matasar MJ; Moskowitz AJ; Moskowitz CH; Noy A; Owens C; Palomba LM; Straus D; von Keudell G; Zelenetz AD; Seshan VE; Younes A
    Blood Cancer J; 2020 Jul; 10(7):74. PubMed ID: 32678074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years.
    Barzenje DA; Cvancarova Småstuen M; Liestøl K; Fosså A; Delabie J; Kolstad A; Holte H
    PLoS One; 2015; 10(7):e0131158. PubMed ID: 26147646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.
    Cencini E; Puccini B; Rigacci L; Fabbri A; Kovalchuk S; Mannelli L; Benelli G; Carfagno T; Simontacchi G; Bocchia M; Bosi A
    Leuk Lymphoma; 2018 Jun; 59(6):1420-1426. PubMed ID: 28994343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standard R-CHOP therapy in follicular lymphoma and diffuse large B-cell lymphoma.
    Tomita N; Takasaki H; Fujisawa S; Miyashita K; Ogusa E; Kishimoto K; Matsuura S; Sakai R; Koharazawa H; Yamamoto W; Fujimaki K; Fujita H; Ishii Y; Taguchi J; Kuwabara H; Motomura S; Ishigatsubo Y
    J Clin Exp Hematop; 2013; 53(2):121-5. PubMed ID: 23995108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular adnexal follicular lymphoma: a multicenter international study.
    Rasmussen PK; Coupland SE; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; McKelvie P; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Heegaard S
    JAMA Ophthalmol; 2014 Jul; 132(7):851-8. PubMed ID: 24763920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03.
    MacManus M; Fisher R; Roos D; O'Brien P; Macann A; Davis S; Tsang R; Christie D; McClure B; Joseph D; Jayamohan J; Seymour JF
    J Clin Oncol; 2018 Oct; 36(29):2918-2925. PubMed ID: 29975623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
    Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
    Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?
    Janikova A; Bortlicek Z; Campr V; Kopalova N; Benesova K; Belada D; Prochazka V; Pytlik R; Vokurka S; Pirnos J; Duras J; Mocikova H; Mayer J; Trneny M
    Leuk Lymphoma; 2015; 56(8):2350-6. PubMed ID: 25426666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.